P
AVNS icon

Pitcairn’s Avanos Medical AVNS Stock Holding History

Pitcairn’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,992
Closed -$208K – 632
2025
Q2 		$208K Sell
16,992
-643
-4% -$8.09K 0.01% 665
2025
Q1 		$253K Buy
17,635
+345
+2% +$5.39K 0.02% 633
2024
Q4 		$275K Buy
17,290
+2,074
+14% +$41K 0.02% 609
2024
Q3 		$366K Sell
15,216
-2,080
-12% -$47.5K 0.02% 535
2024
Q2 		$345K Buy
17,296
+1,356
+9% +$26.4K 0.02% 543
2024
Q1 		$317K Buy
15,940
+1,606
+11% +$31K 0.02% 563
2023
Q4 		$322K Sell
14,334
-473
-3% -$9.76K 0.02% 522
2023
Q3 		$299K Sell
14,807
-1,338
-8% -$30.3K 0.03% 503
2023
Q2 		$413K Buy
16,145
+4,561
+39% +$120K 0.03% 424
2023
Q1 		$345K Buy
11,584
+566
+5% +$16.4K 0.03% 458
2022
Q4 		$298K Sell
11,018
-806
-7% -$19.7K 0.03% 469
2022
Q3 		$258K Buy
11,824
+764
+7% +$20K 0.03% 472
2022
Q2 		$302K Buy
11,060
+200
+2% +$5.75K 0.03% 433
2022
Q1 		$364K Buy
10,860
+92
+0.9% +$2.96K 0.03% 453
2021
Q4 		$373K Buy
10,768
+2,162
+25% +$69.9K 0.02% 450
2021
Q3 		$268K Buy
+8,606
New +$292K 0.02% 531

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Pitcairn's AVNS Position: Q3 2025 in Review

Pitcairn sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 16,992 shares — an estimated $208K sold.

Pitcairn first reported a position in AVNS in Q3 2021 and held it in 16 quarters. The position peaked at $413K in Q2 2023. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

  • Pitcairn reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
  • Pitcairn sold 16,992 Avanos Medical shares in Q3 2025, an estimated $208K.
  • Pitcairn first reported a position in Avanos Medical in Q3 2021 and held it in 16 quarters.
  • Pitcairn's Avanos Medical position peaked at $413K in Q2 2023.
  • 276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on Pitcairn's 13F filing for Q3 2025, filed 12 Nov 2025.